Bugao, Neonita B.

HRN: 01-22-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CEFTRIAXONE 1G (VIAL)
12/30/2024
01/05/2025
IV
2g
OD
T/C Iatrogenic Cushing Syndrome; T2DM: CKD Sec To DKD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: